Interaction between urokinase-type plasminogen activator (uPA) and its receptor (uPAR) localizes cellular proteolysis and promotes cellular proliferation and migration, effects that may contribute to the pathogenesis of lung inflammation a nd neoplasia.
Introduction
Degradation of extracellular matrix by serine proteinases and metalloproteinases has been implicated in the pathogenesis of lung injury and lung neoplasia (1) (2) (3) . These enzymes influence inflammatory cell traffic or cancer cell invasiveness via the dissolution of basement membranes and extracellular matrix (4) (5) (6) (7) . Plasmin, a serine protease, is involved in the breakdown of extracellular matrix and basement membrane during tissue degradation. This protease is generated via the action of plasminogen activators such as urokinase (uPA) 1 or tissue plasminogen activator (tPA) and can influence tissue remodeling either directly or through activation of latent collagenases.
uPA is mainly involved in extravascular proteolysis and is implicated in stromal remodeling in acute and chronic lung injury (8) (9) (10) and in metastatic neoplasia (7) .
Interaction of uPA with its cellular receptor has several unique properties that promote plasminogen activation. During the last decade, evidence for the involvement of the uPA system in lung injury and repair or lung neoplasia (1) has steadily increased and it now seems beyond reasonable doubt that uPA-dependent plasminogen activation is central to these processes. Because many biological activities of uPA depend on association with its receptor, uPAR plays a central role in localized uPA-mediated plasminogen activation.
Increased expression of uPA or uPAR has, for example, been inversely correlated with prognosis in lung cancer (11, 12) . Better understanding of the specific pathways that regulate uPAR expression is therefore germane to the pathogenesis of lung injury or the spread of lung neoplasms.
The steady-state of any mRNA reflects its stability as well as synthesis.
Moreover, stability of many mRNAs are major determinants of their abundance. Among the various mechanisms by which different cell types influence mRNA stability, regulation of mRNA decay is a potentially important process determining the level of gene expression. Synthesis of uPAR is regulated by a variety of hormones, growth factors and cytokines either at the transcriptional or posttrancriptional level (13) (14) (15) (16) (17) (18) (19) (20) . Both uPA 5 and uPAR, as well as PAI-1 and -2 are expressed by lung epithelial cells (21-23), and it is now clear that posttranscriptional regulation contributes to the regulation of uPA, uPAR and PAI-1 by these cells (16, (22) (23) (24) (25) (26) .
Expression of uPA and uPAR controls several cellular functions, including epithelial cell adhesion, signaling and mitogenesis, and most of the biological activities of uPA are dependent on its association with the uPAR (4, 13, (27) (28) (29) (30) (31) (32) (33) . The expression of these components by the lung epithelium is tightly regulated during normal physiological processes and is disordered in lung injury or lung cancer. It is noteworthy that the signaling pathways activated by proinflammatory cytokines induce uPAR expression (30) . We therefore postulated that cooperativity between cytokine-mediated signaling and posttranscriptional regulation of uPAR mRNA stability was plausible, albeit not previously described. This possibility was investigated using cultured Beas2B cells as a model system. In these studies, we describe a novel regulatory pathway by which PMA and TGF-β induce uPAR expression at the posttranscriptional level.
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Materials and Methods

Material
Culture media, penicillin, streptomycin, fetal calf serum (FCS) were purchased from Acrylamide, bisacrylamide and nitrocellulose were from BioRad laboratories (Richmond, CA). Anti-uPAR antibody was obtained from American Diagnostics (Greenwich, CT).
XAR X-ray film was purchased from Eastman Kodak (Rochester, NY).
Cell cultures
Human bronchial epithelial cells (Beas2B) were maintained in LHC-9, or RPMI 1640 medium containing 10% heat-inactivated FCS, 1% glutamine and 1% antibiotics as previously described (30) .
Total cellular membrane extraction and Western blotting
Beas2B cells grown to confluence were serum starved overnight with RPMI-glutamine media containing 0.5% BSA. The cells were treated with or without various agents for indicated times and were washed with PBS. Receptor bound uPA was removed by glycine-HCl treatment as described earlier (29) (30) . We used SDS gel electrophoresis and 7 Western blotting to measure functional uPAR at the cell surface. Membrane proteins isolated as described earlier (29) (30) from Beas2B cells were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked with 1% BSA in wash buffer for 1 h at room temperature followed by overnight hybridization with uPAR monoclonal antibody in the same buffer at 4°C, washed and uPAR proteins were detected by enhanced chemiluminescence (ECL).
Plasmid Construction
Plasmid uPAR/pBluescript was obtained from the ATCC. The human uPAR mRNA template containing a complete sequence of uPAR cDNA (nucleotides -16 to1144) from uPAR pBluescript was subcloned to Hind III and Xba I sites of pRC/CMV (Invitrogen) and the sequences of the clones were confirmed by sequencing. The uPAR insert was released by Hind III or Xba I, purified on 1% agarose gels, extracted with phenol/chloroform and used as cDNA probe for Northern blotting.
In vitro transcription
Linearized plasmids containing the human uPAR mRNA transcriptional template of complete uPAR cDNA were transcribed in vitro with T7 or Sp6 polymerase (Ambion).
The uPAR mRNA transcripts were synthesized according to the supplier's protocol except that 50 µCi of [ 32 -P]UTP was substituted for unlabeled UTP in the reaction mixture. Passage through a Sephadex G -25 column removed unincorporated radioactivity. The specific activities of the product were 4.9 X 10 8 .
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Random priming of uPAR cDNA
The full length template of uPAR was released with Hind III or Xba I, purified on 1% agarose gels and labeled with 32 P-dCTP using a rediPrime labeling kit (Amersham, Arlington Heights, IL). Passage through a Sephadex G -25 column removed unincorporated radioactivity. The specific activity of the product was 6 X 10 8 cpm/µg.
Northern blotting of uPAR mRNA
A Northern blotting assay was used to assess the level of uPAR mRNA. Beas2B cells grown to confluence were serum-starved overnight in RPMI-BSA media, then treated with PMA, TGF-β and cycloheximide for varying times (0-24 h) in the same media.
Total RNA was isolated using TRI reagent. RNA (20 µg) was isolated on agarose/formaldehyde gels. After electrophoresis, the RNA was transferred to Hybond N + according to the instructions of the manufacturer. Prehybridization and hybridization was done at 65°C in NaCl (1M) /SDS (1%) and 100 µg/ml salmon sperm DNA. Hybridization was performed with a uPAR cDNA probe (1 ng/ml) labeled to approximately 6 X 10 8 cpm/µg of DNA overnight. After hybridization, the filters were washed twice for 15 min at 65°C, with: 2 X SSC, 1% SDS; 1 X SSC, 1% SDS, and 0.1% SSC, 1% SDS, respectively. The membranes were next exposed to X -ray film at -70° C overnight. The intensity of the bands was measured by densitometry and normalized against that of β-actin.
We also measured the stability of uPAR mRNA in the presence of PMA by transcription chase experiments as described earlier (16) .
Preparation of cytosolic extracts
Beas2B cells treated with or without, PMA or TGF-β were detached from the culture flasks. The cells were washed in PBS, cytosolic extracts were prepared by suspending the cell pellet in a buffer containing 25 mM Tris-HCl (pH 7.9), 0.5 mM EDTA, and 0.1 mM PMSF. The cells lysates were prepared as described earlier (16) . Samples were separated by electrophoresis on a 5% native polyacrylamide gel with 0.25 X tris-borate-EDTA running buffer. The gels were dried and developed by autoradiography at -70°C.
UV cross-linking
We used UV cross-linking assay to confirm the molecular weight of uPAR mRNABp, here we performed uPAR mRNA-protein interaction reaction essentially same as described above. After heparin digestion, the reaction mixture was kept on ice and UV irradiated for 30 min at 2500 µJ. The uPAR mRNA-protein complex was separated on 8% SDS-PAGE, radiolabeled uPAR mRNA-protein complex was visualized by autoradiography.
Northwestern Assay
Alternatively, we confirmed the molecular weight and uPAR mRNA-uPAR mRNABp interaction by Northwestern assay. Cytosolic proteins from Beas2B cells separated on 8%
SDS-PAGE, blotted to nitocellulose membrane. The membrane was blocked with gel shift buffer containing 1% BSA and 20 µg ribosomal RNA for 1 h. The membrane was replaced with fresh buffer containing 32 P-labeled uPAR mRNA (200000 cpm/ml) and incubated for an additional 1 h at RT. The membrane was later washed thrice with 50 ml of gelshift buffer for 10 min each, air dried and exposed to X -ray film. The membrane was later stripped and developed by Western blot using a β-actin monoclonal antibody as described above for equal loading.
Results
Expression of uPAR in lung epithelial cells
Since we previously found that lung epithelial, fibroblasts and pleural mesothelial/ mesothelioma cells express uPAR in vitro ( PMA enhanced uPAR mRNA expression by increasing t he stability of the message (Figure 2b ).
PMA down-regulates the uPAR mRNA-uPAR mRNABp interaction
Strong and rapid induction of uPAR and uPAR mRNA stability by PMA in Beas2B cells prompted us to next evaluate the role of the uPAR mRNA-uPAR mRNABp interaction in the process. This interaction has previously been demonstrated to regulate uPAR mRNA stability (16) . We confirmed that PMA and TGF-β reduced the uPAR mRNA-uPAR 11 mRNABp interaction by about 50% using gel mobility shift (Fig. 3) . Similar results were also found by independent Northwestern and UV cross-linking assays (data not shown).
We also confirmed that the PMA-mediated decrement in t he uPAR mRNA-uPAR mRNABp complex was apparent by 3 h after the treatment and the inhibitory effect is sustained over 24 h (Fig. 4) .
Activation of uPAR mRNABp involves phosphorylation of the uPAR mRNABp.
We next wanted to determine whether PMA-mediated induction of uPAR ( Fig. 1) involved regulation through the interaction of uPAR mRNA with the uPAR mRNABp.
We therefore treated Beas2B cells with PMA for varying time periods and prepared cell lysates. The cell lysates were immunoprecipitated with antibody developed against purified rabbit uPAR mRNABp (26) . The immune-complexes were separated on SDS-PAGE under denaturing condition and were then blotted to nitrocellulose membranes.
The membrane was later developed to detect tyrosine phosphorylation; activation, using an antiphosphotyrosine antibody. The results indicate that PMA induces tyrosine phosphorylation of the uPAR mRNABp (Figure 5a ). When the same samples were subjected to Western blotting using an anti-uPAR mRNABp antibody, we found no significant quantitative variation of the uPAR mRNABp expression after PMA treatment (Fig. 5b) . The results show that PMA induced tyrosine phosphorylation of the uPAR mRNABp in a time dependent manner and that the protein was detectable in phosphorylated form from 6 to 24 h.
Inhibition of Tyrosine Phosphorylation inhibits PMA as well as TGF-β−mediated uPAR expression
Since PMA induced tyrosine phosphorylation of the uPAR mRNABp, we next explored the possibility that posttranscriptional regulation of uPAR expression in epithelial cells involves activation of tyrosine kinases. We treated these cells with PBS, PMA or TGF-β alone or with the tyrosine kinase inhibitor, herbimycin A for 24 h. uPAR expression at the cell surface was determined by Western blotting using an anti-uPAR antibody as described in Figure 1 . Results of these experiments (Fig 6a) demonstrate that PMA and TGF-β induce uPAR and pretreatment of these cells with that herbimycin reversed it's induction by these agents.
Inhibition of Tyrosine Phosphorylation inhibits PMA and TGF-β−mediated uPAR mRNA expression as well as mRNA stability
We also confirmed that herbimycin reversed PMA and TGF-β mediated uPAR expression by inhibiting uPAR mRNA expression (Fig. 6b) . It is well known that PMA as well as TGF-β enhance uPAR mRNA stability as well as transcription (14-16). We therefore analyzed uPAR mRNA stability in the presence of herbimycin and found that PMA enhanced uPAR mRNA stability and that herbimycin reversed PMA-mediated stabilization of uPAR mRNA (Fig. 6c) .
Inhibition of the uPAR mRNA-uPAR mRNABp interaction by herbimycin
We next studied the effect of tyrosine phosphorylation on the PMA and TGF-β−mediated uPAR mRNA-uPAR mRNABp interaction by gel mobility shift assay. Results of these 13 experiments indicate that PMA and TGF-β down regulate the uPAR mRNA-uPAR mRNABp interaction (Fig 7a) . However, inactivation of tyrosine kinases by pretreatment of the cells with herbimycin A reversed the inhibitory effect of PMA and TGF-β. Similar reversal of the uPAR mRNA and uPAR mRNABp interaction was also confirmed by
Northwestern assay (Fig 7b) . We also found that herbimycin reversed PMA and TGF-β mediated tyrosine phosphorylation of the uPAR mRNABp by Western blotting (Fig.7c) .
In a separate experiment, we inhibited PMA-mediated tyrosine phosphorylation of uPAR mRNABp by pretreating the cells with herbimycin and the uPAR mRNABp was immunoprecipitated using an anti-uPAR mRNABp antibody. The immune complexes were separated and the tyrosine phosphorylation of uPAR mRNABp was analyzed by
Western blotting using an anti-phosphotyrosine antibody. As shown in Fig. 7d , pretreatment of Beas2B cells with herbimycin A inhibited PMA mediated tyrosine phosphorylation of uPAR mRNABp ( Fig. 5a and 7b ).
Discussion
Synthesis of uPAR is controlled both at transcriptional and posttranscriptional levels by a variety of hormones and cytokines (14) (15) (16) 18) . In previous studies, we and other investigative teams observed that PMA, TGF-β and cycloheximide increased uPAR mRNA stability in MS-1 cells (16) and other cell lines (14) (15) 18) . We have previously examined various aspects of posttranscriptional regulation in lung epithelial cells (22) (23) (24) .
The choice to examine PMA and TGF-β effects in Beas2B, lung epithelial cell responses are germane to the pathogenesis of acute lung injury and repair. We therefore now extend these observations and demonstrate a newly recognized underlying mechanism by which these same stimuli can induce uPAR expression at the posttranscriptional level in Beas2B cells. We also confirm that these responses involve a posttranscriptional regulatory It has previously been reported that uPAR expression as well as the specific capacity to bind uPA is increased by PMA, EGF, LPS, TGF-β and TNF-α in various cell lines (14-15, 24, 30) . These agents strongly and rapidly induce cell surface uPAR expression, an effect that can be traced back to a rapid, antecedent increase in the cellular level of uPAR mRNA. PMA increases the stability of uPAR mRNA in Beas2B cells, a phenomenon consistent with that we previously reported in MS-1 cells (16) . We found that cytokine-induced uPAR was regulated at the posttranscriptional level in these cells (14, 16) . The increased uPAR mRNA stability in lung-derived epithelial and mesothelioma cells correlates with increased uPAR mRNA and cell surface expression of uPAR. There are precedents for this mode of regulation. Lymphocyte engagement, for example, also stabilizes uPAR mRNA, a process that involves AU-rich sequences present in the uPAR 3'untranslated region (3'UTR) (18) .
Our data now demonstrate that posttranscriptional regulation of uPAR expression further involves activation of tyrosine kinases. The sustained effect of proinflammatory agents on both uPAR protein and mRNA levels suggested the likelihood that tyrosine kinase signaling prolongs the half-life of uPAR mRNA.
Supporting this inference, we found that pretreatment of cells with herbimycin reverses the PMA or TGF-β−mediated increase of uPAR expression. Similarly, we found that 16 genestein, a tyrosine kinase inhibitor, also decreased uPAR expression whereas the tyrosine phosphatase inhibitor sodium orthovanadate potentiated uPAR expression in resting Beas2B lung epithelial cells and it has an additive effect with uPA (40) were subjected to gel mobility shift assay as described in Fig. 3a . 
